SS
Sohini Sandip Tawde
About Sohini Sandip Tawde
Data last updated:
Sohini Sandip Tawde is a Director at Sachio Pharma Bangalore Private Limited (since 2021) and Director at Sumire Lifesciences Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Sachio Pharma Bangalore Private Limited at ₹6.25 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jul 2021 | 2013 | ₹6.25 Cr (FY 2024) | Active | |
| Director | 09 Aug 2023 | 2023 | Active |
Board colleagues of Sohini Sandip Tawde
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandip Bhikaji Tawde | 09232547 | Sachio Pharma Bangalore Private Limited , Sumire Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sohini Sandip Tawde
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sohini Sandip Tawde
Sohini Sandip Tawde currently holds 2 directorships: Sachio Pharma Bangalore Private Limited (Director, since 09 Jul 2021, revenue ₹6.25 Cr (FY 2024)); Sumire Lifesciences Private Limited (Director, since 09 Aug 2023).
Sohini Sandip Tawde was first appointed on 09 Jul 2021 as Director at Sachio Pharma Bangalore Private Limited. The most recent appointment on record is 09 Aug 2023 at Sumire Lifesciences Private Limited.
The current boards of Sohini Sandip Tawde's companies include Sandip Bhikaji Tawde (Sachio Pharma Bangalore Private Limited).